Supriya Lifescience Limited has informed that the European Directorate for the Quality of Medicines (EDQM) has granted Attestation of Inspection (EU-GMP) for Lote API Facility, Ratnagiri, Maharashtra.
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
The company is one of the most profitable companies manufacturing speciality chemicals in India
Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
A committee of two Joint Drugs Controllers has been constituted at CDSCO to monitor the process of inspection, reporting, and subsequent action to ensure compliance to the Drugs & Cosmetics Act, 1940
As per the agreement, NSE-listed Vaishali Pharma Limited will take over the entire domestic and international marketing of Jark Pharma’s portfolio of quality based ayurvedic products
Global pharmaceutical company having a surgical business concept incepted in Dubai
The Halol facility was placed under Import Alert by USFDA.
The investment will enable the company to enter European markets as well as enhance margins in current markets
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
Subscribe To Our Newsletter & Stay Updated
